Growing Sleep Disorder Market

In a recent report released at the Research Reports Blog, they discuss the growing opportunities in the sleeping disorder medication market. Over 80 sleep disorders have been identified, and it is believed that 20% of the American population suffers from these disorders. Visiongain believes that by 2012, the world insomnia market will be worth $1.8 billion.
Most of the drugs on the market are to treat the sleeping disorder insomnia. Since 2005, two new drugs have been introduced to the US market: Ambien CR and Lunesta. There are also a number of generic drugs that cost significantly less, leading to easy market penetration.